35 studies found for:    Thimerosal
Show Display Options
RSS Create an RSS feed from your search for:
Thimerosal
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
Condition: Influenza
Interventions: Biological: CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free;   Biological: CSL Trivalent Inactivated Influenza Vaccine with Thimerosal;   Biological: Placebo with Thimerosal
2 Completed
Has Results
Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations
Condition: Influenza Infection
Interventions: Biological: Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A);   Biological: Thiomersal reduced FluAS25 adjuvanted vaccine (GSK576389A)
3 Completed Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations
Condition: Dermatitis, Contact
Intervention: Biological: TRUE TEST Skin patch test Bioequivalence
4 Completed Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04
Condition: Influenza
Interventions: Biological: Thiomersal free trivalent influenza split vaccine 2003/2004;   Biological: GlaxoSmithKline Biologicals' Influsplit SSW®/Fluarix™ 2003/2004
5 Completed Mercury Levels in Premature and LBW Infants Receiving Thimerosal-containing Vaccines
Condition: Mercury Levels
Intervention:
6 Completed Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03
Condition: Influenza
Interventions: Biological: Thiomersal free trivalent influenza split vaccine 2002/2003;   Biological: GlaxoSmithKline Biologicals' Influsplit SSW®/Fluarix™ 2002/2003
7 Completed
Has Results
Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup
Condition: Influenza
Interventions: Biological: Cell culture derived seasonal trivalent influenza vaccine (cTIV);   Biological: Influenza virus vaccine (egg-derived seasonal trivalent, thiomersal free; eTIV_a).;   Biological: cTIV or eTIV_a;   Biological: cTIV+PV OR eTIV_a+PV
8 Completed
Has Results
Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
Condition: Prophylaxis Hepatitis B
Interventions: Biological: Engerix™-B (thiomersal-free) 20µg;   Biological: 10 μg Engerix™-B (preservative-free);   Biological: placebo
9 Completed Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns
Condition: Hepatitis B
Interventions: Biological: HepavaxGene (thiomersal free);   Biological: Engerix B
10 Completed Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine
Condition: Prophylaxis Hepatitis B
Intervention: Biological: Hepatitis B vaccine
11 Completed
Has Results
Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children
Condition: Influenza
Interventions: Biological: Fluarix;   Biological: Fluzone
12 Completed
Has Results
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Condition: Influenza Infection
Interventions: Biological: GSK investigational vaccine GSK1557482A;   Biological: Fluzone®
13 Completed Immunogenicity and Safety of GSK Biologicals' FluLaval® TF
Conditions: Influenza;   Influenza Vaccines
Intervention: Biological: FluLaval® TF
14 Completed
Has Results
Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control
Conditions: Influenza Vaccines;   Influenza Virus
Interventions: Biological: GSK Biologicals' influenza vaccine GSK1557482A;   Biological: Vaxigrip
15 Unknown  Study of Dehydrex in Patients With Corneal Erosion
Conditions: Corneal Diseases;   Recurrence
Intervention: Drug: Dehydrex
16 Recruiting Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients
Condition: Human Influenza
Intervention: Biological: Trivalent influenza vaccine (inactivated and fragmented).
17 Completed Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial
Condition: Healthy
Intervention: Biological: DTP/HB/Hib Vaccine
18 Completed
Has Results
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA
Condition: Influenza
Interventions: Biological: CSL425;   Biological: Placebo
19 Completed Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults
Condition: Influenza
Interventions: Biological: Influenza vaccine (A/H3N2, A/H1N1, and B strains);   Biological: Fluarix
20 Completed
Has Results
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children
Condition: Influenza Caused by the Novel Influenza A (H1N1) Virus
Intervention: Biological: CSL425

Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results
Indicates status has not been verified in more than two years